No abstract

No abstract

<p>Objetivo: identificar la asociación que existe entre estrés y depresión respecto al apego al tratamiento en pacientes con Diabetes Mellitus tipo 2 en una unidad de medicina familiar de la ciudad de Mérida, Yucatán, México. Métodos: encuesta transversal a 101 pacientes con Diabetes Mellitus tipo 2. Se utilizó el test de Morinsky-Green Levine para adherencia; el test de Holmes-Rae para estrés y el test de Zung para depresión. La asociación entre apego al tratamiento, estrés y depresión con control metabólico se efectuó de acuerdo con los criterios de la American Diabetes Association mediante estadística inferencial. Resultados: 65% de los pacientes presentó estrés, 26% depresión y en 82% se encontró falta de adherencia al tratamiento. El estrés estuvo asociado al descontrol glucémico (RM 3.7, IC 95%, 1.4-9.6, p=0.006) y a la falta de apego al tratamiento (RM 7.2, IC 95%, 2.3-22.5, p&lt;0.05) y a su vez esta falta de adherencia al tratamiento se encontró asociada al descontrol glicémico (RM 4.3, IC 95%, 1.4-12.9, p=0.01). Conclusión: el estrés está asociado a un mal apego a tratamiento en Diabetes Mellitus tipo 2.</p>

No abstract

Delay in treatment was largely due to system delay. Only a few variables explained this delay. Clinical stage had the strongest effect on initiation of first oncologic treatment.

Supracondylar humerus fractures are a common injury in children, males are more likely to be injured by extension, and the speed in medical treatment is an important issue.

No abstract

Objective: To know the frequency of people with hypozincemia in a group of Mexican patients with Diabetic Foot Ulcers (DFU) m and its relationship with metabolic and clinical profile. Material and methods: Cross-sectional, analytical, and observational study in patients with and without DFU, treated in Family Medicine Units from Instituto Mexicano del Seguro Social (IMSS) in Mérida, Yucatán, México. Frequency of hypozincemia (Zn serum < 70 g/ml) and its relationship with the levels of Glycosylated Hemoglobin (HbA1c), cholesterol and triglycerides was analyzed. Results: 70% of patients with DFU and 25% without DFU had hypozincemia (OR = 5.2, 95% CI 2.139-12.65, p = 0.0004). Patients with hypozincemia were older and the highest prevalence was between 50 and 60 years. The average area of the DFU showed no differences in patients with and without hypozincemia. Patients with DFU reported higher levels of HbA1c, cholesterol, triglycerides, BMI, and blood pressure compared to patients without DFU. Hypozincemia was associated with higher BMI values. Conclusion: The frequency of hypozincemia in diabetic patients with UPD is high and is behaving as a risk factor for presenting UPD, so its identification should be routine.